Hellman Jordan Management CO Inc Reata Pharmaceuticals Inc Transaction History

Hellman Jordan Management CO Inc

  • $58.9 Million
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 26, 2022
SELL
$25.61 - $110.96 $171,791 - $744,319
-6,708 Closed
0 $0
Q3 2021

Oct 26, 2021
BUY
$100.0 - $143.02 $219,000 - $313,213
2,190 Added 48.47%
6,708 $675,000
Q2 2021

Jul 21, 2021
SELL
$78.27 - $151.29 $9,079 - $17,549
-116 Reduced 2.5%
4,518 $639,000
Q1 2021

May 06, 2021
BUY
$94.25 - $132.81 $436,754 - $615,441
4,634 New
4,634 $462,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Hellman Jordan Management CO Inc Portfolio

Follow Hellman Jordan Management CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hellman Jordan Management CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Hellman Jordan Management CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email